The Bridge to healthcare shortens the journey
Healthcare professionals have great insight into how products used in medical technology, diagnostics, and pharmaceutical applications should be designed to be effective. There is a tremendous willingness to collaborate with industry. Uppsala BIO is therefore working to create a Bridge to healthcare.
 Photo: Markus Marcetic |
|
In the Mälardalen region there are four university hospitals, one of them Uppsala University Hospital. They are all of central importance, not only in terms of the care and clinical research they perform but also, in a broader sense, in terms of the region’s life science sector, including its companies. There is tremendous potential in this. |
Those who work in healthcare develop considerable insight into how products should be designed in order to be effective. When products are being developed, prototypes or candidate drugs also need to be tried out in alpha/beta tests or in clinical trials. Here, too, close cooperation is necessary.
By eliminating obstacles and creating incentives so that it becomes apparent that everyone stands to gain, we can make collaboration more efficient.
The government’s delegation for cooperation in clinical research, along with Uppsala BIO’s members, have asked Uppsala BIO to address these issues. Uppsala BIO is therefore creating a focus group. The goal is for healthcare, in close collaboration with clinical research, to more clearly constitute an even more powerful engine for the life science sector in the region.
In February 2010, VINNOVA announced that Uppsala BIO's project The Innovative Hospital will be granted 7,5 MSEK (0,75 MEUR) over three years to realize the plans formulated in the project. The project will be owned and administred by Uppsala University Hospital, in collaboration with Uppsala BIO, Uppsala Innovation Centre, Almi Företagspartner and Uppsala Regional Council, who also will co-finance the project. Pressreleases on the decision are available in Swedish from VINNOVA and from Uppsala BIO.
For questions about Uppsala BIO’s focus group and our results, please contact Dr Erik Forsberg, Uppsala BIO.